TB-500 Research Guide: Thymosin Beta-4 Mechanisms, Wound Healing, and Preclinical Applications

By Justin Cartier

This guide is part of our broader overview of peptides for healing and recovery.

TB-500 is a synthetic peptide based on the active part of a natural protein called thymosin beta-4, or Tβ4 for short. Researchers reach for it because of one thing: healing. In animal work it speeds wound repair. Muscle and tendon bounce back quicker, and damaged heart tissue gets some protection too.^[4]

Research use only — TB-500 is a lab compound, not a medicine, and is not for human use. See our peptide legal and research-use guide for the full policy.

The interesting part is the how. Tβ4 helps a cell hold a pool of “G-actin,” the building block cells lean on to change shape and crawl. The synthetic fragment keeps that same job. It nudges cells to migrate, helps build new blood vessels, and keeps cells alive in injured tissue. This guide walks through the cell-level mechanism, what the animal research shows on injury recovery, heart protection, muscle repair, and wound healing, where the hair-growth story really stands, and how to vet material before you buy it.

What is TB-500 and how does it work?

TB-500 copies the actin-binding stretch of thymosin beta-4, the protein that manages a cell’s actin supply. Cassimeris and colleagues, writing in the Journal of Cell Biology, showed Tβ4 sequesters most of the free G-actin in human cells, holding the balance between loose G-actin and the assembled F-actin that gives a cell its scaffolding.^[1] That balance is what lets cells move, reshape, and rebuild tissue. The peptide keeps that activity in a smaller, easier-to-absorb amino acid chain.

The mechanism is unusually well mapped for a research peptide. A 2003 paper in Wound Repair and Regeneration, led by Philp, found that a synthetic peptide carrying Tβ4’s actin-binding domain promotes dermal wound repair in diabetic and aged mice.^[2] That’s the result that made the short fragment a credible stand-in for the full-length protein.

Cellular mechanisms: migration, blood vessels, and survival

Holding actin is only the start. The peptide also moves cells, grows vessels, and keeps tissue alive after an injury. It helps skin cells and the endothelial cells that line blood vessels migrate, it sparks new vessel growth in animals, and it steadies injured heart muscle in rodent heart-attack models.

The wound-healing evidence runs deep. Malinda and colleagues, in the Journal of Investigative Dermatology, reported that Tβ4 speeds wound healing and helps skin cells migrate, which cools inflammation and closes the wound faster.^[3] Blood vessels come next. A 2010 study in Biochimica et Biophysica Acta from Jo’s group showed it raises VEGF, a key vessel-growth signal, by stabilizing the HIF-1α protein.^[5] The heart is the showpiece. Srivastava and colleagues, in the Annals of the New York Academy of Sciences, found Tβ4 cardioprotective after a heart attack, helping heart and vessel cells survive and repair.^[4]

TB-500 and injury recovery in preclinical models

Injury recovery is what built its reputation. The models vary a lot: rat tendon cuts, mouse skin wounds, rabbit eye scrapes, pig heart attacks. Across all of them, treated animals close wounds faster, score higher on tissue-repair checks, and get back to normal function sooner than controls. The signal is strongest in soft tissue, meaning skin, tendon, and ligament, and in heart muscle after blood flow is cut off. Animals in these studies tend to show less inflammation, quicker healing of small wounds, calmer inflammatory markers in the blood, and more collagen laid down. It reads less like a single drug effect and more like faster, cleaner tissue regeneration.

Researchers often pair it with BPC-157, since the two heal through different routes. BPC-157 works on the eNOS-VEGF pathway and gut protection. TB-500 works on actin and the growth factors that quiet local inflammation. The combination, run at roughly equal doses by weight, is the one people call the “Wolverine Stack,” and it has held up as safe across published rodent studies. There’s still no human approval for either.

Does TB-500 affect hair growth?

Here the evidence is thin. A couple of small mouse studies report that topical Tβ4 lifts follicle density and shortens the resting telogen phase, and one rabbit study describes faster fur regrowth after shaving. None of it has been repeated in a registered human trial, and it’s dwarfed by the wound-healing and heart data. Treat the peptide as a tool for testing hair-biology ideas, not as a proven hair-growth compound.

Heart, skin, and eye research highlights

The heart is where the large-animal results turn heads. In pig and mouse heart-attack models, treatment shrank the damaged zone, kept the heart pumping better, and pulled repair cells into the injured muscle. Skin work tells a quieter version of the same story: shorter healing time and better collagen layout in diabetic wound models. Rabbit eye-scrape studies saw the surface heal a day or two faster. Topical eye and skin forms are the formats tested most. Oral capsules don’t appear in the peer-reviewed record at all, so don’t assume they match injectable research material.

Dosing, routes, and TB-500 in pills

Published rodent studies give it by injection, either under the skin or into muscle. The intact peptide barely survives the gut, which is exactly why pills and capsules don’t show up in peer-reviewed work. What’s sold as a capsule generally isn’t equal to the injectable material. Preclinical doses tend to land around 2 to 10 milligrams per kilogram in rats, scaled down for larger animals. No human dose has been established, because no human approval exists.

Safety, side effects, and legal status

The preclinical safety signals are mild. No oral LD50 has turned up at any tested dose, and side effects in animal studies are mostly local irritation at the injection site. One flag matters most for researchers: TB-500 sits on the World Anti-Doping Agency’s banned list, in and out of competition, since it’s a compound athletes have tried to misuse. Beyond that, it carries the same research-only legal status most lab peptides carry in Canada and the US — see our guide to buying peptides legally in Canada for the full breakdown.

When your protocol needs verified material, shop research peptides in Canada and check the batch COA on arrival.

Purity and sourcing for researchers

Does the TB-500 I’m buying actually contain what the label says? The only real way to know is the batch’s own Certificate of Analysis (COA) from an independent lab, not a number on a seller’s website. Thymosin beta-4’s molecular formula, C212H350N56O78S, gives it a molecular weight of about 4,963 Da^[6], so a real mass-spec trace on the COA should land within a few daltons of that figure. HPLC purity should read 98 percent or higher, with the actual chromatogram included, not just a bare percentage. If a vial’s COA is missing, isn’t batch-specific, or doesn’t match those two numbers, the material inside may not be what the label claims.^[7]

Reviv Peptides supplies it at 10 mg per vial with a third-party COA, HPLC purity at 99 percent or higher, and mass-spec verification confirming that ~4,963 Da mass. View the TB-500 10mg product page, or compare it with the BPC-157 and TB-500 Wolverine Stack if you’re studying both pathways at once.

TB-500 questions

What is TB-500 and how does it work?

It’s a synthetic version of the actin-binding part of thymosin beta-4. It manages the cell’s actin supply, helps cells migrate, raises VEGF to grow new blood vessels, and supports cell survival in injured tissue.

Does TB-500 increase hair growth?

Limited mouse and rabbit data hint that Tβ4 may shorten the resting hair phase and speed fur regrowth, but there aren’t any registered human trials confirming it. The evidence is far smaller than for wound healing or heart repair.

How much TB-500 is used and how is it given?

Preclinical rodent studies use roughly 2 to 10 milligrams per kilogram by injection under the skin or into muscle. Human dosing hasn’t been set, since no human approval exists. This is research material only.

What about TB-500 in pills or capsules?

The intact peptide is poorly absorbed in the gut, so pills don’t show up in peer-reviewed research. Almost all published work uses injection.

Can TB-500 be used with BPC-157?

They’re often combined in research because the mechanisms fit together. BPC-157 acts on the eNOS-VEGF path and the gut lining, while TB-500 acts on actin and cell migration. That pairing is the “Wolverine Stack” people refer to.

Is TB-500 FDA approved or legal?

No. TB-500 isn’t approved as a drug or supplement by the FDA or Health Canada, so it’s sold and studied strictly as a research chemical, under the same legal framework as other lab peptides — see our Canada peptide legal guide for the details. It’s also on the World Anti-Doping Agency’s banned list for competitive athletes.

Key data point: in rodent and large-animal injury models, TB-500 and the full-length thymosin beta-4 protein sped tissue repair by lifting cell migration, new blood vessel growth, and collagen, with the strongest evidence in skin, tendon, and heart tissue.^[2][4]

Summary

TB-500 sits where actin biology meets regenerative research. Its preclinical record is large, consistent, and repeatable across rodent and large-animal models, and it’s strongest in wound healing, tissue regeneration, and heart protection. The hair-growth claim, by contrast, rests on a few small animal studies and nothing more. The synthetic fragment keeps the healing effects of the parent Tβ4 protein in a smaller, easier-to-study amino acid chain. Like everything in this class, it carries no approved human use and is sold for research only.

Sources: [1] Thymosin beta-4 sequesters G-actin in human cells, PubMed. [2] Thymosin beta-4 actin-binding peptide promotes dermal wound repair, PubMed. [3] Thymosin beta-4 accelerates wound healing, PubMed. [4] Thymosin beta-4 is cardioprotective after myocardial infarction, PubMed. [5] Thymosin beta-4 induces VEGF via HIF-1α, PubMed. [6] Thymosin beta 4 molecular formula and weight, PubChem (NCBI). [7] Reference standards for synthetic peptide purity testing, PMC.

Justin Cartier

The Reviv Peptides Research Team is a collective of science writers and researchers dedicated to producing evidence-based, peer-reviewed-grade content about research peptides. Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data — including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank). All content is written in a strict preclinical/laboratory context; none of our editorial material is intended as medical advice. Every guide is reviewed for scientific accuracy against published peer-reviewed literature.